Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01677507Phase 4Completed
Phase 4 trial of timolol and latanoprost in Glaucoma, sponsored by University of Michigan. Primary endpoint: Variation in Intraocular Pressure Between Individuals at 1 week. Started Aug 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01677507.